DEVELOPMENT OF PK/PD BIOMARKERS
FOR THE INDIVDUALIZATION OF DRUG THERAPY
Your contact person
Forschungsschwerpunkt
We develop and validate
1. phosphorylation of a protein in the NO-cGMP pathway as a diagnostic and therapeutic marker in endothelial dysfunction,
2. exosomes as biomarkers for drug clearance.
Mission
Biomarker development for precision dosing
Background
Appropriate biomarkers are often not available for a precise individual drug dosing.
Most visited
